Blue Owl Capital Holdings LP Cabaletta Bio, Inc. Transaction History
Blue Owl Capital Holdings LP
- $185 Million
- Q2 2025
A detailed history of Blue Owl Capital Holdings LP transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Blue Owl Capital Holdings LP holds 1,125,000 shares of CABA stock, worth $3.04 Million. This represents 0.93% of its overall portfolio holdings.
Number of Shares
1,125,000Holding current value
$3.04 Million% of portfolio
0.93%Shares
1 transactions
Others Institutions Holding CABA
# of Institutions
91Shares Held
79.2MCall Options Held
406KPut Options Held
90.9K-
Bain Capital Life Sciences Investors, LLC Boston, MA9.68MShares$26.1 Million4.41% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.83MShares$23.8 Million0.02% of portfolio
-
Jennison Associates LLC8.5MShares$22.9 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.79MShares$18.3 Million0.01% of portfolio
-
Cormorant Asset Management, LP Boston, MA5MShares$13.5 Million0.77% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $78.3M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...